Tech Company Financing Transactions
Exagen Diagnostics Funding Round
On 11/4/2013, Exagen Diagnostics landed $25 million in funding from CRG.
Transaction Overview
Company Name
Announced On
11/4/2013
Transaction Type
Debt
Amount
$25,000,000
Round
Undisclosed
Investors
CRG (Luke Duster)
Proceeds Purpose
Exagen intends to use the proceeds to grow its U.S. sales force to 25 -- 30 representatives, fueling already strong revenue growth in SLE+ as well as the company's pipeline of rheumatology tests.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
1261 Liberty Way C
Vista, CA 92081
USA
Vista, CA 92081
USA
Phone
Website
Email Address
Overview
Exagen Diagnostics is a rheumatology specialty company that focuses on the diagnosis, prognosis and monitoring of autoimmune connective tissue disease.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Ron Rocca
Chief Financial Officer
Kamal Adawi
Chief Medical Officer
Arthur Weinstein
Chief Scientific Officer
Thierry Dervieux
Vice President
Brian Littlefield
Vice President
Tami Powell
VP - Finance
Mark Hazeltine
VP - Marketing
Brian McEvilly
VP - Operations
Claudia Ibarra
VP - Sales
John Wegener
Browse more venture capital transactions:
Prev: 11/4/2013: OwnZones Media Network venture capital transaction
Next: 11/4/2013: NeuroSky venture capital transaction
Share this article
Where The Data Comes From
Our team works diligently to report on every notable VC transaction. VC investment data records reported here come from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs